MEDICAL DEVICES– THE IMPLANT CARD FOR PATIENT WITH AN IMPLANTED DEVICE

Regulation EU 2017/745 introduced a new requirement for the manufacturer of implantable medical device. The manufacturers of implantable devices must…

READ

MEDICAL DEVICES – REQUIREMENTS REGARDING THE INFORMATION SUPPLIED WITH THE DEVICE

Starting with the entry into force of the new European Regulation 2017/745 on May 2020, the information on medical devices…

READ

MARKET ACCESS – NEW ITALIAN DECREE ON THE PROCEDURES FOR PRICING AND REIMBURSEMENT OF MEDICINAL PRODUCTS

On 1st August 2019, the text of a new Decree from the Italian Ministry of Health and the Ministry of…

READ

REGULATORY AFFAIRS – MANDATORY USE OF COMMON EUROPEAN SUBMISSION PORTAL FOR MUTUAL RECOGNITION PROCEDURE/DECENTRALIZED PROCEDURE

According to the eSubmission Roadmap, from July 1st 2019, the use of the Common European Submission Portal (CESP) has become…

READ

REGULATORY AFFAIRS – AIFA CLARIFICATIONS ON THE SUBMISSION OF MARKETING AUTHORIZATION TRANSFER APPLICATIONS OF NATIONAL MUTUAL RECOGNITION PROCEDURE/DECENTRALIZED PROCDURE FOR MEDICINAL PRODUCTS

AIFA clarifications on the submission of Marketing Authorization Transfer applications of national/MRP/DCP medicinal products With a recently published notice, on…

READ

MEDICAL DEVICES – EXTENSION OF THE APPLICATION FIELD AND MEDICAL DEVICES WITH NON-MEDICAL PURPOSES (Annex XVI)

The new European Regulation 2017/745 will bring many innovations. One of these concerns the extension of the Regulation application field….

READ

MEDICAL DEVICES – POST MARKET SURVEILLANCE: THE INTRODUCTION OF PERIODIC SAFETY UPDATE REPORT

As part of an ever-increasing improvement in post-marketing surveillance activities for medical devices, the new EU regulation 2017/745 introduces the…

READ

MEDICAL DEVICES – IMPACT OF THE NEW REGULATION ON MEDICAL DEVICES CONTAINING SUBSTANCES

Currently, many over-the-counter medical devices are substances or combinations of substances. Medical devices containing substances are the medical devices that…

READ

CLINICAL TRIAL – ITALY TOWARDS THE IMPLEMENTATION OF THE NEW EU REGULATION 536/2014

In view of the new European legislation (EU Regulation 536/2014) about the clinical trial, the Law No. 3 of 11…

READ

REGULATORY AFFAIRS – ASSENT-BY-DEFAULT PROCEDURE UPDATE

With the new disposition DG/512/2019 of 12 March 2019, AIFA has updated the application of the assent-by-default procedure, in force…

READ